Latest filing published 24 Jan 2024 for BIOLIDICS LIMITED, €62k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Wong Kong Leong: trading record in brief
All filings by Wong Kong Leong on record concern Biolidics Limited. In total, 3 filings cover trades dated from 24 July 2023 to 24 January 2024.
On the open market, the record shows 1 purchase worth €633k and 2 sales worth €202k. Netting one side against the other leaves €431k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2024 alone, the filings show no purchases and 1 sale.
The latest filing, published on 24 January 2024, reports an open-market sale of €62k in Biolidics Limited. The most recent open-market purchase was published on 24 July 2023, 1,203 days ago. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SGX. Past trades are no guide to future returns.
Companies and markets linked to Wong Kong Leong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,500,000 shares@ SGD 0.01230.5% of flowShareSGX-STISIN SGXE89830751SGX:XZ2HVYJJ6VZPUM75
- 12,879,800 shares@ SGD 0.015969.5% of flowShareSGX-STISIN SGXE89830751SGX:7BPX78DCYUA05SWX
- 57,123,300 shares@ SGD 0.0163100.0% of flowShareSGX-STISIN SGXE89830751SGX:Y4EAZ3TDZE4775OMCanonical exit: 22 Oct 2023 (T+90)
3 of 3 declarations